ASTS
AST SpaceMobile, Inc.
ASTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CPAY
Corpay, Inc.
CPAY has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CPAY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Stable |
CPAY's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CPAY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $456 | — |
| Cheap | 19x | $352 | -23% |
| Fair | 23x | $413 | -9.5% |
| Current | 25x | $456 | — |
| Expensive | 28x | $518 | +14% |
Historical ranges are pointers, not guarantees.
CPAY's PE is in its expensive range at 25x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CPAY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CPAY, with profitability improving.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CPAY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $31.05 | +71% |
| Q3 2026 | $18.17 | +23% |
| Q2 2026 | $16.42 | +12% |
| Q1 2026 | $16.70 | +17% |
| Q4 2025 | $15.03 | +7.6% |
| Q3 2025 | $14.72 | +5% |
| Q2 2025 | $14.71 | +6.9% |
| Q1 2025 | $14.25 | +6% |
| Q4 2024 | $13.97 | +5.8% |
CPAY has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CPAY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +18% |
| Q2 2026 | $1.3B | +21% |
| Q1 2026 | $1.3B | +25% |
| Q4 2025 | $1.2B | +21% |
| Q3 2025 | $1.2B | +14% |
| Q2 2025 | $1.1B | +13% |
| Q1 2025 | $1B | +7.5% |
| Q4 2024 | $1B | +10% |
CPAY's revenue has grown year over year for 22 quarters in a row: $1.4B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 45% | +0.3 points |
| Q2 2026 | 35% | -8.2 points |
| Q1 2026 | 50% | +8 points |
| Q4 2025 | 45% | -2 points |
| Q3 2025 | 45% | -0.9 points |
| Q2 2025 | 44% | -0.9 points |
| Q1 2025 | 42% | 0 points |
| Q4 2024 | 47% | +2 points |
CPAY has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CPAY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$735M | -$305.2M |
| Q2 2026 | $1.4B | +30% |
| Q1 2026 | -$107.7M | +$11.2M |
| Q4 2025 | $760.3M | +26% |
| Q3 2025 | -$429.8M | -221% |
| Q2 2025 | $1.1B | +119% |
| Q1 2025 | -$118.9M | -138% |
| Q4 2024 | $604.6M | -11% |
CPAY has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CPAY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +60K shares |
| 1 year | -6.7% | -4.7M shares |
| 3 years | -11% | -8.2M shares |
| 5 years | -21% | -17.3M shares |
| Available history | -27% | -24M shares |
CPAY has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $706.5M |
| Q2 2026 | $326.6M |
| Q1 2026 | $786M |
| Q4 2025 | $500.2M |
| Q3 2025 | $191.7M |
| Q2 2025 | $32.2M |
| Q1 2025 | $58.7M |
| Q4 2024 | $248.8M |
CPAY spent $2.3B buying back its own shares over the past year, about four times what it spent the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CPAY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 3.0x | Elevated |
| Q4 2024 | 3.0x | Elevated |
CPAY's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.7 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CPAY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.0 | Overbought |
| Stochastic | 66.5 | Neutral |
CPAY's weekly RSI is 72 (overbought) and its Stochastic is 67 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CPAY PE vs Technology Sector
| Metric | CPAY | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 28x | 9.9% below |
| PE % | 70 | 35 | 35 pts above |
CPAY is trading at 25x earnings, in line with the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CPAY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $413.9 | 10% above |
| 20 week MA | $399.7 | 14% above |
| 50 week MA | $354.3 | 29% above |
| 100 week MA | $339.4 | 34% above |
| 200 week MA | $304.8 | 50% above |
CPAY has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CPAY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $285.8 | $270.5 | -5.4% |
| 2021 | $270.5 | $223.7 | -17% |
| 2022 | $223.7 | $181.2 | -19% |
| 2023 | $181.2 | $282.6 | +56% |
| 2024 | $282.6 | $341.2 | +21% |
| 2025 | $341.2 | $310.2 | -9.1% |
| 2026 YTD | $310.2 | $456.0 | +47% |
CPAY has the edge over ASTS on returns for 2026, with the stronger performance.